UPDATE 2-Array BioPharma gets FDA nod for melanoma combo treatment


The U.S. Food and Drug Administration said on Wednesday it approved Array BioPharma Inc's oral combination treatment for use in patients with the deadliest form of skin cancer. A view shows the U.S. Food and Drug Administration headquarters in Silver Spring, Maryland August 14, 2012.



from Biotech News